185 related articles for article (PubMed ID: 7780142)
1. Cytokine activation during attacks of the hyperimmunoglobulinemia D and periodic fever syndrome.
Drenth JP; van Deuren M; van der Ven-Jongekrijg J; Schalkwijk CG; van der Meer JW
Blood; 1995 Jun; 85(12):3586-93. PubMed ID: 7780142
[TBL] [Abstract][Full Text] [Related]
2. [Hyperimmunoglobulin D syndrome].
Drenth JP; Denecker NE; Prieur AM; Van der Meer JW
Presse Med; 1995 Sep; 24(26):1211-3. PubMed ID: 7567850
[TBL] [Abstract][Full Text] [Related]
3. Interleukins and their antagonists but not TNF and its receptors are released in post-ERP pancreatitis.
Messmann H; Vogt W; Falk W; Vogl D; Zirngibl H; Leser HG; Schölmerich J
Eur J Gastroenterol Hepatol; 1998 Jul; 10(7):611-7. PubMed ID: 9855088
[TBL] [Abstract][Full Text] [Related]
4. Impact of continuous hemofiltration on cytokines and cytokine inhibitors in oliguric patients suffering from systemic inflammatory response syndrome.
van Bommel EF; Hesse CJ; Jutte NH; Zietse R; Bruining HA; Weimar W
Ren Fail; 1997 May; 19(3):443-54. PubMed ID: 9154661
[TBL] [Abstract][Full Text] [Related]
5. Favorable preliminary experience with etanercept in two patients with the hyperimmunoglobulinemia D and periodic fever syndrome.
Takada K; Aksentijevich I; Mahadevan V; Dean JA; Kelley RI; Kastner DL
Arthritis Rheum; 2003 Sep; 48(9):2645-51. PubMed ID: 13130485
[TBL] [Abstract][Full Text] [Related]
6. Immunoglobulin D enhances the release of tumor necrosis factor-alpha, and interleukin-1 beta as well as interleukin-1 receptor antagonist from human mononuclear cells.
Drenth JP; Göertz J; Daha MR; van der Meer JW
Immunology; 1996 Jul; 88(3):355-62. PubMed ID: 8774350
[TBL] [Abstract][Full Text] [Related]
7. Increased circulating cytokine receptors and ex vivo interleukin-1 receptor antagonist and interleukin-1beta production but decreased tumour necrosis factor-alpha production after a 5-km run.
Drenth JP; Krebbers RJ; Bijzet J; van der Meer JW
Eur J Clin Invest; 1998 Oct; 28(10):866-72. PubMed ID: 9793002
[TBL] [Abstract][Full Text] [Related]
8. Pretreatment cytokine profiles of peripheral blood mononuclear cells and serum from patients with rheumatoid arthritis in different american college of rheumatology response groups to methotrexate.
Seitz M; Zwicker M; Villiger PM
J Rheumatol; 2003 Jan; 30(1):28-35. PubMed ID: 12508386
[TBL] [Abstract][Full Text] [Related]
9. Location of the gene causing hyperimmunoglobulinemia D and periodic fever syndrome differs from that for familial Mediterranean fever. International Hyper-IgD Study Group.
Drenth JP; Mariman EC; Van der Velde-Visser SD; Ropers HH; Van der Meer JW
Hum Genet; 1994 Dec; 94(6):616-20. PubMed ID: 7989036
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of proinflammatory cytokines and their inhibitors during the course of meningococcal infections.
van Deuren M; van der Ven-Jongekrijg J; Demacker PN; Bartelink AK; van Dalen R; Sauerwein RW; Gallati H; Vannice JL; van der Meer JW
J Infect Dis; 1994 Jan; 169(1):157-61. PubMed ID: 8277177
[TBL] [Abstract][Full Text] [Related]
11. Serum p55 and p75 tumour necrosis factor receptors as markers of disease activity in juvenile chronic arthritis.
Gattorno M; Picco P; Buoncompagni A; Stalla F; Facchetti P; Sormani MP; Pistoia V
Ann Rheum Dis; 1996 Apr; 55(4):243-7. PubMed ID: 8733441
[TBL] [Abstract][Full Text] [Related]
12. Limited efficacy of thalidomide in the treatment of febrile attacks of the hyper-IgD and periodic fever syndrome: a randomized, double-blind, placebo-controlled trial.
Drenth JP; Vonk AG; Simon A; Powell R; van der Meer JW
J Pharmacol Exp Ther; 2001 Sep; 298(3):1221-6. PubMed ID: 11504824
[TBL] [Abstract][Full Text] [Related]
13. Activation of the cytokine network in familial Mediterranean fever.
Gang N; Drenth JP; Langevitz P; Zemer D; Brezniak N; Pras M; van der Meer JW; Livneh A
J Rheumatol; 1999 Apr; 26(4):890-7. PubMed ID: 10229412
[TBL] [Abstract][Full Text] [Related]
14. Hyperimmunoglobulinemia D and periodic fever syndrome. The clinical spectrum in a series of 50 patients. International Hyper-IgD Study Group.
Drenth JP; Haagsma CJ; van der Meer JW
Medicine (Baltimore); 1994 May; 73(3):133-44. PubMed ID: 8190036
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-10 and soluble tumor necrosis factor receptors in cerebrospinal fluid of children with bacterial meningitis.
Kornelisse RF; Savelkoul HF; Mulder PH; Suur MH; van der Straaten PJ; van der Heijden AJ; Sukhai RN; Hählen K; Neijens HJ; de Groot R
J Infect Dis; 1996 Jun; 173(6):1498-502. PubMed ID: 8648229
[TBL] [Abstract][Full Text] [Related]
16. Proinflammatory cytokine inhibitors, TNF-alpha and oxidative burst of polymorphonuclear leukocytes in the pathogenesis of sepsis in newborns.
Sikora JP; Chlebna-Sokół D; Dabrowska I; Lipczyński D; Chrul S
Arch Immunol Ther Exp (Warsz); 2001; 49(2):155-61. PubMed ID: 11348020
[TBL] [Abstract][Full Text] [Related]
17. Molecular analysis of the MVK and TNFRSF1A genes in patients with a clinical presentation typical of the hyperimmunoglobulinemia D with periodic fever syndrome: a low-penetrance TNFRSF1A variant in a heterozygous MVK carrier possibly influences the phenotype of hyperimmunoglobulinemia D with periodic fever syndrome or vice versa.
Stojanov S; Lohse P; Lohse P; Hoffmann F; Renner ED; Zellerer S; Kéry A; Shin YS; Haas D; Hoffmann GF; Belohradsky BH
Arthritis Rheum; 2004 Jun; 50(6):1951-8. PubMed ID: 15188372
[TBL] [Abstract][Full Text] [Related]
18. Soluble tumour necrosis factor receptors, tumour necrosis factor and interleukin-6 in serum in granulocytopenic patients with fever.
Steinshamn S; Brekke OL; Waage A
Br J Haematol; 1995 Apr; 89(4):719-24. PubMed ID: 7772508
[TBL] [Abstract][Full Text] [Related]
19. Relationship between soluble tumor necrosis factor (TNF) receptors and TNF alpha during immunotherapy with interleukin-2 and/or interferon alpha.
Landmann R; Keilholz U; Scheibenbogen C; Brockhaus M; Gallati H; Denz H; Bargetzi M; Ludwig C
Cancer Immunol Immunother; 1994 Feb; 38(2):113-8. PubMed ID: 8306366
[TBL] [Abstract][Full Text] [Related]
20. Effect of inflammatory attacks in the classical type hyper-IgD syndrome on immunoglobulin D, cholesterol and parameters of the acute phase response.
Simon A; Bijzet J; Voorbij HA; Mantovani A; van der Meer JW; Drenth JP
J Intern Med; 2004 Sep; 256(3):247-53. PubMed ID: 15324368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
